Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is unchanged from the same period last year. The company reported $15.649 million in sales this quarter. This is a 14.67 percent decrease over sales of $18.340 million the same period last year.